Atlas Trials

Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)

RecordFirmDate
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) (NCT04113616)Kartos Therapeutics, Inc.2019-09-25

Track Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN) automatically

Every clearance here is in the API, with alerts when new ones post.